OMNIPEN (AMPICILLIN) Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Omnipen (ampicillin), and what generic alternatives are available?
Omnipen (ampicillin) is a drug marketed by Wyeth Ayerst and is included in two NDAs.
The generic ingredient in OMNIPEN (AMPICILLIN) is ampicillin/ampicillin trihydrate. Three suppliers are listed for this compound. Additional details are available on the ampicillin/ampicillin trihydrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OMNIPEN (AMPICILLIN)?
- What are the global sales for OMNIPEN (AMPICILLIN)?
- What is Average Wholesale Price for OMNIPEN (AMPICILLIN)?
Summary for OMNIPEN (AMPICILLIN)
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 61 |
| DailyMed Link: | OMNIPEN (AMPICILLIN) at DailyMed |
-patent-expirations.png "OMNIPEN (AMPICILLIN) drug patent expirations")
US Patents and Regulatory Information for OMNIPEN (AMPICILLIN)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Ayerst | OMNIPEN (AMPICILLIN) | ampicillin/ampicillin trihydrate | CAPSULE;ORAL | 060624-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Ayerst | OMNIPEN (AMPICILLIN) | ampicillin/ampicillin trihydrate | FOR SUSPENSION;ORAL | 060625-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Ayerst | OMNIPEN (AMPICILLIN) | ampicillin/ampicillin trihydrate | CAPSULE;ORAL | 060624-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
